Subscribe to the Pharma Lab Newsletter
Latest news
Authenticx expands pharmacovigilance AI to automate downstream safety workflows with accuracy
Authenticx, whose AI turns millions of healthcare conversations into system-critical intelligence for pharmaceutical, payer and provider organisations, announced expanded capabilities for its pharmacovigilance (PV)...
Hamamatsu and AIxMed announce collaboration to evaluate ScanPilot integration in cytology research workflows
Hamamatsu Corporation and AIxMed, a developer of software for digital cytology workflows, has announced a technical collaboration to evaluate the integration of AIxMed's ScanPilot...
Carterra enables Anthropic’s autonomous AI protein design study through its HT-SPR binding platforms
Carterra, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, is highlighting the role of Carterra...
Merck expands biosafety testing laboratory in Singapore to Strengthen services across Asia Pacific
Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the...
Aurisco Pharmaceutical’s Chinese manufacturing plant gets green light from US Food and Drug Administration
Aurisco Pharmaceutical announced that its manufacturing site in Yangzhou, China, has passed a US Food and Drug Administration (USFDA) pre-approval inspection, making it the first...
Intertek Envirolab launches new unified brand to strengthen operational sustainability services
Intertek, a leading Total Quality Assurance provider to industries worldwide, has launched Intertek Envirolab, bringing trusted environmental and analytical expertise and Intertek’s global operational...
Intertek expands global fire detection testing capabilities with ISO 7240 and AS ISO 7240 accreditation
Intertek, a leading Total Quality Assurance provider to industries worldwide, has expanded the accredited fire detection testing capabilities of its UK Life Safety &...
From research biomarkers to clinical practice: overcoming quality, compliance and implementation bottlenecks in Alzheimer’s disease testing – a Q&A with Dr Lewis Penny
For many years, confirming the biology of Alzheimer’s disease has relied on tests that are invasive, expensive, difficult to access or all three. Lumbar...
